Esketamine (depression) - Benefit assessment according to §35a Social Code Book V

Report documents

1. Extract of dossier assessment

   Esketamine (depression) - Benefit assessment according to §35a Social Code Book V

   published on

   01.06.2021

   Document type

   PDF document, 403 kB, EN, not accessible

   Download file : Extract of dossier assessment (PDF document, 403 kB, EN, not accessible)
2. Dossier assessment

   Esketamine (depression) - Benefit assessment according to §35a Social Code Book V

   published on

   01.06.2021

   Document type

   PDF document, 1 MB, DE, not accessible

   Download file : Dossier assessment (PDF document, 1 MB, DE, not accessible)

Dossier assessment

Project details

Project no.

A21-24

Commission

Commission awarded on 03.03.2021 by the Federal Joint Committee (GBA).

Report type

Dossier assessment

Status

Commission completed

Department/Division

Drug Assessment

Topic

Mental and emotional wellbeing

Note

After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.

Connected Projects

1. Dossier assessment

   Esketamine (depression, acute treatment) - Benefit assessment according to §35a Social Code Book V

   Project no.

   A21-25

   Last updated

   19.08.2021

   Status: Commission completed